TWO SIGMA ADVISERS, LP - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 142 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2019. The put-call ratio across all filers is 2.57 and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2021$600,000
+212.5%
11,467
-8.0%
0.00%
+100.0%
Q1 2020$192,000
-75.6%
12,467
-45.7%
0.00%
-50.0%
Q4 2019$788,000
-24.0%
22,967
-83.4%
0.00%
-33.3%
Q3 2019$1,037,000
-51.6%
138,767
-15.9%
0.00%
-40.0%
Q2 2019$2,141,000
+39.7%
164,967
+31.1%
0.01%
+25.0%
Q1 2019$1,533,000
+376.1%
125,867
+345.3%
0.00%
+300.0%
Q4 2018$322,00028,2670.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders